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Third generation cephalosporins (3GC) are one of the main choices for treatment of
infections caused by multidrug-resistant (MDR) Gram-negative bacteria. Due to their
overuse, an increasing trend of resistance to 3GC has been observed in developing
countries. Here, we describe fecal colonization of 3GC-resistant (3GCr) Escherichia
coli in healthy infants (1–12 months old) living in rural areas of Bangladesh. We found
that stool samples of 82% of infants (n = 100) were positive for 3GCr E. coli with a
mean ± standard deviation of 6.21 ± 1.32 log10 CFU/g wet weight of stool. 3GCr
E. coli encompasses an average one third (33%) of the total E. coli of stool. Almost 77%
(n = 63) of these 3GCr E. coli were MDR (or resistant to≥3 classes of antibiotics). Around
90% (n = 74) of 3GCr E. coli were extended spectrum beta-lactamase (ESBL)-producing
in which blaCTX−M−group−1 was the predominant (96%, n = 71) ESBL-gene followed by
blaTEM (41%, n = 30) and blaOXA−1 (11%, n = 8). A significant proportion (26.5%, n = 22)
of 3GCr E. coli was pathogenic, comprising two types, enteroaggregative (EAEC, n = 19)
and enteropathogenic (EPEC, n = 3). Colonization of 3GCr E. coli in infant guts was
not associated with demographic characteristics such as age, sex, mode of delivery,
maternal and infant antibiotic use, disease morbidity, and feeding practices. The high
rate of colonization of 3GCr E. coli in infants’ guts is a serious public health concern
which needs immediate attention and warrants further studies to explore the cause.
Keywords: colonization, multidrug-resistant, E. coli, ESBL, third generation cephalosporins
INTRODUCTION
The rapid rise of multidrug-resistant (MDR) bacterial infections is a major public health concern
and a growing threat to the global health security. Unregulated use of broad spectrum antibiotics
and widespread reservoirs of these pathogens are main contributors to this problem (Hilty et al.,
2012). Broad spectrum antibiotics, in particular third generation cephalosporins (3GC), are among
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the most frequently prescribed drugs for the treatment of
infections caused by Enterobacteriaceae (Pereira et al., 2004;
World Health Organization [WHO], 2017). Failure of treatment
with these antibiotics has increasingly been reported due to
the emergence of extended spectrum beta-lactamases (ESBLs)
during the last two decades (Pitout and Laupland, 2008). Several
studies have suggested that children are more likely to be
exposed to antibiotics both directly (Alexander et al., 2011;
Saari et al., 2015) and indirectly, through exposure to antibiotics
taken by their mothers (Verani et al., 2010; Macones et al.,
2012; Ledger and Blaser, 2013; de Tejada, 2014). This direct
and/or indirect consumption of antibiotics might thus affect
infants’ intestinal microflora, including Escherichia coli, which
is one of the first bacterial species that colonizes the infant gut
(Hewitt and Rigby, 1976).
Antimicrobial resistance in commensal bacteria is worrisome
due to its ability to spread to pathogens (Munk et al., 2018).
Recent studies have showed that school children and children
up to 2 years of age were colonized by E. coli resistant to broad
spectrum antibiotics and ciprofloxacin, respectively (Gurnee
et al., 2015; Ferjani et al., 2017). However, there is no information
on the carriage rate and abundance of this antibiotic-resistant
E. coli in relation to the total number of E. coli present in the
gut. In addition, there is no data available on the carriage rate
of MDR E. coli, including ESBL-producing E. coli, among infants
under 1 year old. Therefore, this study evaluated the prevalence
and rate of colonization of this organism during the early life of
infants. We determined the prevalence, abundance, and carriage
rate of 3GC-resistant (3GCr) E. coli, including pathogenic E. coli,
by analyzing culturable E. coli in infant’s stool samples.
MATERIALS AND METHODS
Ethics Statement
The research and the ethical review committees of icddr,b
approved and monitored the progress of the study. Informed
written consent was obtained from mothers of all infants either
by signature or, for those who were not literate, by thumbprint
after verbal communication. Samples were identified with codes
to preserve anonymity. A witness also signed each informed-
consent form. All authors vouch for the completeness and
accuracy of the data and analyses presented.
Study Design, Site, and Enrollment of
Participants
We conducted a cross-sectional study of children <1 year of
age living in five rural villages of Matlab and Hajiganj, sub-
districts of Chandpur district of Bangladesh, between March
and October 2017. Hajigonj has a total area of 189 km2 with
327,367 people living in 64,257 households at 11 unions, whereas
Matlab Uttar has a total area of 279 km2 with 382,195 people
in 62,418 households at 15 unions (DGHS Health Bulletin,
2014). According to the The World Bank (2016) the crude birth
rate for Bangladesh is 18.95 per 1000 people as of 2016, so
an approximation for the number of infants in Hajigonj and
Matlab Uttar is 6,200 and 7,250, respectively, or less than 13,500
total infants (2016). For study sites we included one union
from each sub-district. A total of 100 households (50 from each
union) containing one infant (age ≤1 year) in each household
were enrolled in the study after obtaining written informed
consent from the mothers of enrolled infants. A pre-tested survey
questionnaire was used to collect information on age, sex, mode
of delivery, maternal and child antibiotic consumption, disease
morbidity, and feeding practices.
Sample Collection
A total of 100 stool samples were collected from 100 infants
located in the selected households using sterile stool containers
provided earlier to all the mothers on the date of the interview.
Assuming an infant population in Hajigong and Matlab Uttar of
13,500, the sample size of 100 stool samples would imply a margin
of error of approximately 10% with 95% confidence interval for
prevalence rates of 3GCr E. coli (Dhand and Khatkar, 2014).
The field staff collected the samples on the following day and
transported it to icddr,b laboratory (Dhaka, Bangladesh) on ice
for microbiological analyses within 4 h.
Enumeration and Isolation of E. coli
Both total and 3GCr E. coli were enumerated using the drop
plate method as described previously (Herigstad et al., 2001). In
brief, MacConkey agar plates (Becton Dickson, MD) with and
without fixed concentrations of cefotaxime (1.0 µg/mL) were
used to enumerate 3GCr E. coli and total E. coli, respectively.
A total of four 10-fold serial dilutions (10−1 to 10−4) of each stool
sample were made and 50 µl from each dilution was inoculated
onto MacConkey agar plates with and without antibiotic added
to the culture media. All plates were incubated at 37◦C for
18 h and the number of colony forming units (CFUs) per gram
wet weight of stool sample were counted from the dilution of
readable range. Proportion of 3GC-sensitive (3GCs) E. coli CFUs
per gram feces (CFU/g) count was calculated by subtracting
3GCr CFU/g count from corresponding total E. coli CFU/g.
Further, proportion of 3GCr E. coli count was measured in
respect to the total E. coli count obtained on MacConkey agar
plate. At least three colonies from each sample were confirmed as
E. coli by API-20E (bioMerieux, France) and stored at−80◦C for
further characterization.
Antibiotics Susceptibility Test
Antibiotic susceptibility of E. coli (one isolate per sample) was
determined by standard disk diffusion technique following the
Clinical and Laboratory Standards Institute (CLSI) guidelines
(Patel, 2017). The antibiotics used in this study were ampicillin
(10 µg), gentamycin (10 µg), tetracycline (30 µg), meropenem
(10 µg), imipenem (10 µg), ceftriaxone (30 µg), cefotaxime
(30 µg), ceftazidime (30 µg), cefepime (30 µg), colistin (10 µg),
ciprofloxacin (5 µg), nalidixic acid (30 µg), azithromycin
(15 µg), trimethoprim/sulfamethoxazole (25 µg), nitrofurantoin
(30 µg), and chloramphenicol (30 µg) (Oxoid, United Kingdom).
The zone of inhibition was measured and the isolates were
classified as resistant, intermediate, or sensitive according to
the interpretation guideline provided by the CLSI (Patel, 2017).
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An isolate was considered MDR if resistant to three or more
classes of antibiotics.
Test for Extended Spectrum
Beta-Lactamase (ESBL)
Extended spectrum beta-lactamase was tested by combination
disk test (CDT) as described by CLSI (Patel, 2017). Disks
containing a 3GC, including cefotaxime, CTX (30 µg)
or ceftazidime, CAZ (30 µg) alone and in combination
with clavulanic acid (CLA, 10 µg) were applied (Oxoid,
United Kingdom). The zone of inhibition around the CTX or
CAZ disk combined with CLA was compared with the inhibition
zone around CTX or CAZ disks alone. The test was considered
positive for ESBL-production if the inhibition zone diameter was
≥5 mm larger with CLA than without (Patel, 2017).
PCR for ESBL Genes and
E. coli Pathotypes
All 3GCr E. coli were tested for ESBL genes considered priorities
due to their clinical relevance, specifically: blaCTX−M−group−1,
blaSHV , blaTEM, and blaOXA−1. These genes were tested by
PCR using primer sequences and PCR conditions as described
previously (Islam et al., 2017). The pathotypes of E. coli (EPEC,
ETEC, EAEC, EIEC, and STEC) were identified by multiplex
PCR of different pathogenic genes according to the procedure
described earlier (Talukdar et al., 2013).
Statistical Data Analysis
Data were entered in SPSS 20.0 (IBM Inc., Chicago, IL,
United States). Data cleaning, statistical analysis and graphical
presentation were done in Stata 13.0 (College Station, TX,
United States) and R-3.4.2 (R Core Team, 2014). E. coli
concentrations were log10 transformed in order to assess
the association between demographic variables with 3GCr
E. coli carriage using chi-square test and non-parametric
Mann–Whitney U-test. Population counts of the susceptible
and resistant isolates from the same infant were compared
using Wilcoxon Rank-Sum test on the paired data. Statistical
significance was determined using alpha = 0.05 for all tests except
for the Wilcoxon Rank-Sum test which stratified analyses by age
(1–3, 4–6, 7–9, and 10–12 months). For this, the conservative
Bonferroni correction was applied to adjust alpha to 0.0125
(0.5/4) to correct for multiple comparisons.
RESULTS
Carriage of 3GCr E. coli in Infant’s Fecal
Sample
Of the 100 stool samples from infants, 82% were positive for 3GCr
E. coli. Mean count ± standard deviation for total E. coli was
6.86 ± 1.56 log10 E. coli CFU/g of stool while the mean count
of 3GCr E. coli was 6.21 ± 1.32 log10 CFU/g. On average, 3GCr
E. coli encompasses approximately one third of (33%) of the total
E. coli present/g wet weight of stool.
Antibiotic Susceptibility of 3GCr E. coli
All the 3GCr (n = 82) E. coli isolates were tested for susceptibility
against a panel of 13 antibiotics. Resistance to multiple antibiotics
other than 3GCr was very common, with 77% (n = 63) of isolates
classified as MDR. None of the isolates were resistant to colistin
or carbapenem (Figure 1).
Prevalence of ESBLs Among 3GCr
E. coli Isolates
CDT of all 3GCr E. coli (n = 82) isolates revealed that more than
90% (n = 74) were ESBL-producing. Among ESBL-producing
isolates, 96% (n = 71) were positive for blaCTX−M−group−1, 41%
(n = 30) for blaTEM, and 11% (n = 8) for blaOXA−1. Of the
8 CDT negative isolates, 4 were positive for blaCTX−M−group−1
indicating that these isolates might have co-produced ESBL and
AmpC enzymes. Given the high rates of positivity for detection
of blaCTX−M−group−1, further molecular characterization for
resistance genes was not conducted; carriage of multiple
mechanisms of resistance is possible but was not explored.
Prevalence of E. coli Pathotypes Among
3GCr E. coli Isolates
Analysis of virulence genes among 3GCr isolates revealed that
23% (n = 19) of the isolates were positive for genes specific for
EAEC (aatA, aaiC) and 3.6% (n = 3) of the isolates were positive
for genes specific for EPEC (bfp, eae). No other virulence genes
were detected (lt, st, ipaH, and ial).
Determinants of 3GCr E. coli Carriage
Among Infants
Statistical analysis of results did not reveal any significant
association between the presence of 3GCr E. coli in infant stool
and characteristics of the infant, including gender, religion, age,
FIGURE 1 | Prevalence of 3GCr E. coli resistant to different classes of
antibiotics in infants aged from 1 to 12 months (n = 82). AMP, ampicillin; AZM,
azithromycin; FEP, cefepime; NA, nalidixic acid; CIP, ciprofloxacin; SXT,
sulfamethoxazole; TE, tetracycline; CN, gentamycin; F, nitrofurantoin; C,
chloramphenicol; MEM, meropenem; CT, colistin; IMP, imipenem; 3GCr, third
generation cephalosporins resistant.
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mode of delivery, feeding practice of child, diarrheal history, and
maternal and child antibiotic consumption (Table 1). Moreover,
association between the rate of colonization of 3GCr E. coli in
the child’s gut and demographic characteristics of infant (age,
p = 0.5; delivery mode, p = 0.8; infant and mother antibiotic
consumption, p = 0.2, p = 0.4; and infant diarrhea, p = 0.2) were
not statistically significant in non-parametric Mann–Whitney
U-test (Table 2). Therefore, the presence or abundance of 3GCr
E. coli in infant stools in this study could not be explained
by some of the most common risk factors, including prior
exposures to antibiotics.
Age-Wise Distribution of Fecal Carriage
of 3GCr E. coli in Respect to 3GCs E. coli
We calculated the mean count of 3GCr E. coli among infants of
the same age groups and plotted the distribution with 1 month
intervals in order to determine if the CFU count of resistant
microflora changes with infant age. Analysis of mean count of
3GCr up to 12 months showed that log10 CFU mean count of
3GCr even at 3 months of age was high (6.43 log10) and consistent
in subsequent months (Figure 2), indicating early appearance
of 3GCr E. coli in infants. However, the percentage of infants
infected with resistant E. coli population (3GCr and MDR) was
progressively increased as infant age grown by months (Figure 3).
We compared the differences between 3GCr and 3GCs E. coli
counts among infants of the same age groups at 1–3, 4–6, 7–9,
and 10–12 months of age to examine whether 3GCr E. coli
co-exist with the 3GCs favorably without selective pressure of
TABLE 1 | Demographic characteristics of infants with and without fecal carriage
of third generation cephalosporins resistant (3GCr) E. coli.
Characteristics 3GCr E. coli p-Value
Positive,
n = 82 (%)
Negative,
n = 8 (%)
Sex (Male) 44 (54) 3 (38) 0.472
Religion (Muslim/Hindu) 72 (88) 5 (63) 0.087
Age ≤6 months 33 (40) 5 (63) 0.275
Mode of delivery (CS)∗ 27 (32) 3 (38) 1.000
Mode of delivery (NVD)∗ 27 (32) 3 (38) 1.000
Exclusively breast
feeding
1 (1) 0 1.000
Exclusively formula
feeding
1 (1) 0 1.000
Complementary
feeding
80 (98) 7 (88) 1.000
Diarrhea (Yes) 9 (11) 0 0.593
Antibiotic consumption
(6 months before)
53 (65) 3 (38) 0.149
Other complication
(Cold)
47 (57) 2 (25) 0.135
Maternal antibiotic
consumption
12 (15) 1 (13) 1.000
∗NVD, normal vaginal delivery; CS, cesarean section. ∗Mode of Delivery (CS and
NVD) was obtained for 64 cases, and information from the remaining 36 cases was
not available. Number in the parentheses indicates percentage.
TABLE 2 | Association between demographic variables and third generation
cephalosporins resistant (3GCr) E. coli colonization in infants’ gut.
Factors Characteristics Frequency (n) 3GCr E. coli
mean count
(CFU/g wet
weight of stool)
p-Value
Infant age Age <= 6 33 3.2 × 106 0.630
Age > 6 49 2.1 × 106
Mode of
delivery
NVD 27 3.3 × 106 0.665
CS 27 2.4 × 106
Child
antibiotics
Yes 53 3.2 × 106 0.259
No 29 1.6 × 106
Child
diarrhea
Yes 9 1.3 × 106 0.632
No 70 2.2 × 106
Maternal
antibiotics
Yes 12 4.2 × 106 0.758
No 70 2.3 × 106
NVD, normal vaginal delivery; CS, cesarean section.
antibiotics. There was no significant difference in the population
of 3GCr and 3GCs E. coli using Wilcoxon Rank-Sum test
at any age group except for the oldest one, 10–12 months
(p = 0.011) (Figure 4), suggesting that 3GCr E. coli can
stably persist like 3GCs E. coli from early months of life.
Notably, statistical significance in the difference in 3GCr and
3GCs E. coli amongst infants 10–12 months old is borderline
significant compared to the Bonferroni adjusted significance
level of alpha = 0.0125 for the age-stratified Wilcoxon Rank-
Sum test.
DISCUSSION
We found an extremely high prevalence of both 3GCr E. coli
(82%) and ESBL-producing E. coli (74%) in stool samples of
healthy infants living in rural areas of Bangladesh. Despite the
relatively small sample size (n = 100) chosen based on logistic
constraints, the high prevalence rates are likely representative of
Bangladeshi infants under 1 year old in the study area within a
margin of error of 10% (with 95% confidence interval). Even with
the associated uncertainty, this is the highest prevalence of ESBL-
producing E. coli in healthy human guts observed to date. For
example, in a study in Tunisia, the prevalence of MDR E. coli
was 6.6% in children aged between 6 and 12 years (Ferjani et al.,
2017). The rates of 3GCr E. coli in healthy children at various ages
was reported as 2.9% in Sweden, 2.7% in Portugal, and 10% in
Senegal (Guimaraes et al., 2009; Kaarme et al., 2013). The fecal
carriage rate of ESBL-producing Enterobacteriaceae in healthy
children (0–59 months) was much higher (59%) in central Africa
(Farra et al., 2016). None of these studies have reported the data
on culturable 3GCr E. coli as a proportion of total culturable
E. coli in stool samples. In our study we found that around one
third of the total E. coli colonies obtained in culture were 3GCr,
which is alarming.
Frontiers in Microbiology | www.frontiersin.org 4 April 2019 | Volume 10 | Article 640
fmicb-10-00640 March 30, 2019 Time: 16:22 # 5
Islam et al. Fecal Colonization With Multidrug-Resistant E. coli
FIGURE 2 | Variations in carriage rates of 3GCr E. coli in infants at different ages from 3 to 12 months. The log10 mean count of 3GCr CFU from infant at 1 and
2 month of age was excluded because only one infant of each month was obtained for these time periods. Error bars are the standard errors of the results for each
age group. 3GCr, third generation cephalosporins resistant.
FIGURE 3 | Age wise distribution of prevalence of 3GCr, MDR, and ESBL-P
E. coli in infant stool samples. 3GCr, third generation cephalosporins resistant;
ESBL-P, ESBL-producing; MDR, multidrug-resistant.
The difference between 3GCr and 3GCs E. coli gives an
indication of fitness costs for the maintenance of resistance
within the gut microbial community. The proportion of 3GCr
amongst the total E. coli (sum of 3GCr and 3GCs E. coli)
was not significant in infants at different age groups, indicating
that the competitiveness of resistant bacteria with normal
residential flora within the gut is not influenced by age. There
may be a low fitness cost associated with persistence and
dissemination of resistance. Indeed, Cottell et al. (2012) suggest
a low fitness cost associated with plasmid (pCT) carrying
the resistance gene blaCTX−M−14 for E. coli, as the E. coli
were able to persist and disseminate readily even in the
absence of selective pressure from antibiotics (Cottell et al.,
2012). Our findings also displayed congruence with previous
reports demonstrating that tetracycline- and ampicillin-resistant
isolates persist continuously without any selective pressure
of antibiotics in the gut of different age groups of children
(Karami et al., 2006, 2008).
The implication of this high load of 3GCr E. coli is substantial
in the context of child health safety. Antibiotic resistant E. coli
and other common commensals of the gut including Klebsiella
spp. and Acinetobacter spp. are amongst the leading causes of
community-acquired serious infection in Southeast Asia. In a
cross sectional study at five sites across Southeast Asia, Saha
et al. (2018) found that only 17% of possible serious bacterial
infections (pSBI) identified in young children were resistant
to first line antibiotics. Resistant infections, as compared to
susceptible infections, are linked with worse outcomes. For
example, in Tanzania, children with septicemia caused by bacteria
producing extended-spectrum beta-lactamases were almost twice
as likely to die compared to non-ESBL infections (71% mortality
rate vs. 39%) (Blomberg et al., 2007). In the present study,
the observed high carriage rate and high relative proportion
of culturable 3GCr E. coli may harbinger higher rates of 3GCr
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FIGURE 4 | Comparative analysis of carriage rates (in CFU/g wet weight of stool) of 3GCr and 3GCs E. coli within similar age group of infants. (A) 1–3 months of
age, (B) 4–6 months of age, (C) 7–9 months of age, and (D) 10–12 months of age. 3GCr, third generation cephalosporins resistant; 3GCs, third generation
cephalosporins sensitive; CFU, colony forming unit.
E. coli as a proportion of pSBI infections. Further research
linking fecal carriage of resistant bacteria to risks of resistant
infections is warranted.
Apart from increasing the risk of resistant infections, high
carriage of 3GCr Enterobacteriaceae in the gut results in
shedding through infant stool and thus contributes to an elevated
risk of exposure to nearby people and animals. There is a
common belief among illiterate or less literate mothers in the
community that infant stool is not a health hazard or harmful,
especially in comparison to adult stool (Yeager et al., 1999;
Gil et al., 2004). According to a national survey during the
period from 2012 to 2013 in Bangladesh, feces of about 61%
children of age 0–2 years were disposed unsafely where the
percentage was much higher in rural areas (67%) compared
to urban areas (40%) (Bangladesh Bureau of Statistics [BBS]
and United Nations Children’s Fund [UNICEF], 2014). Thus
household members including mothers or caregivers are exposed
to fecal MDR bacteria through unsafe disposal of infant feces.
Similarly, improper disposal of infant’s stool in front yards
or nearby ditches may contribute to transmission of these
resistant bacteria to domestic and wild birds and/or other animals
(Hasan et al., 2012).
The 3GCr E. coli isolates in this study were predominantly
resistant to azithromycin and ciprofloxacin, among other
antibiotics (Figure 1). Azithromycin is the first line of choice for
treatment of shigellosis in children (Centers for Disease Control
and Prevention [CDC], 2006) and a second line of choice for
treatment of shigellosis in adults (World Health Organization
[WHO], 2005). Although no infants were reported to be
suffering from shigellosis during the study period, shigellosis
has been identified as a major contributor to moderate-to-
severe diarrheal disease in neighboring Mirzapur (Kotloff et al.,
2013). Management of this infection might be complicated due
to the high prevalence of azithromycin resistance in the study
community. Among other antibiotics, ciprofloxacin resistance
was found among 37% of 3GCr isolates, which is even higher than
a previous report that showed resistance in 19% of E. coli obtained
from healthy children (Gurnee et al., 2015). Interestingly, only
29% of E. coli isolates in this study were resistant to tetracycline,
a first generation antibiotic which is less commonly used for the
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treatment of E. coli infections in the community (Calva et al.,
1996; Domínguez et al., 2002). Tetracycline is not prescribed
in children due to its effect on the growth of bones and teeth
(Sánchez et al., 2004). It suggests that by reducing the use
of antibiotics in humans and animals, it is possible to reduce
the burden of resistant microorganisms and this can eventually
restore the efficacy of the existing antibiotics even in a setting
like Bangladesh where overuse of antibiotics and burden of AMR,
both are way too high.
Our study demonstrated that infant’s guts serve as a
reservoir of E. coli resistant to multiple antibiotics including
3GCr and fluoroquinolones, which are critical for the
treatment of many infectious diseases in humans (World
Health Organization [WHO], 2017). High rates of ESBL-
producers among 3GCr isolates in the present study is alarming
because patients with community acquired infections as
well as their household members carrying ESBL-producing
Enterobacteriaceae may spread resistance to other people
in their community (Valverde et al., 2008). This can be
explained by the overall high prevalence of ESBL E. coli
infections in the community. A recent study in Bangladesh
has reported that 34% of all clinical isolates of E. coli from
patients with extra-intestinal infections were ESBL-producing
(Khan et al., 2018).
The probable cause of colonization with ESBL-producing
Enterobacteriaceae among pre-school children in Laos was
reported due to misuse of antibiotics (Stoesser et al., 2015). In our
study, we did not observe this: there was no significant association
between colonization and reported previous use of antibiotic
treatment among infants. Previous studies have suggested that
acquisition of antimicrobial resistant bacteria or antimicrobial
resistant genes in the infant gut might occur during and/or
after the delivery (Zhang et al., 2011). Specifically, mothers’ flora
during normal vaginal delivery or environmental flora during
caesarian (C-section) delivery colonize the infant gut (Zhang
et al., 2011). Therefore, AMR bacteria from the mother or
hospital environment may contribute to infant carriage. For
example, a study carried out in Tunisia showed that 20% of
patients acquired 3GCr E. coli in their gut due to nosocomial
infection (Maamar et al., 2016). In our study, we did not find
any significant differences in the level of colonization with
3GCr E. coli between infants with normal vaginal delivery
and infants delivered through C-section (Tables 1, 2). In
Bangladesh, a recent study showed that delivery by C-section
increased from 3.5 to 23% between 2004 and 2014 (Khan
et al., 2017) and it is a common practice that prophylactic
antibiotics are used before and after the surgery. During
post-operative care mothers start to breastfeed the newborn
while still on antibiotic treatment. This leads to transfer of
antibiotics in its active form to infants and thus their gut
microbiota may shift to survive in an antibiotic selective
environment (Mathew, 2004). Further in Dhaka, Bangladesh,
a significant proportion of newborns (98%) receive antibiotics
(sulfonamides, fluoroquinolones, metronidazole, penicillins, etc)
before 6 months of age (Rogawski et al., 2017), which renders
the selective environment for antibiotic-resistant bacteria. Even
in a very low concentration of antibiotics, fitness cost for
microorganisms to become resistant is lower than becoming
antibiotic susceptible (Sandegren, 2014). Surprisingly, in our
study neither history of antibiotic use or previous record of
hospitalization was associated with 3GCr colonization nor were
gender, religion and feeding practices. The lack of association
may be due to the high rate of colonization combined with
relatively small sample size (n = 100). The low proportion of
infants without 3GCr limits statistical analyses. Therefore, further
studies, particularly focused on larger sample sizes, are needed to
identify the causes of the high rate of antibiotic resistance carriage
among infants under 1 year old in this setting.
CONCLUSION
The high rate of intestinal carriage with MDR microorganisms
among infants in rural Bangladesh is a serious concern that
can jeopardize the management of infectious diseases. In
addition, shedding of high number of MDR microorganisms
through infant feces increases the risk of widespread
transmission of these microorganisms in the community
and environment. This study raises important questions
about how the acquisition of resistant microorganisms
takes place in infants’ guts within the first 3 months
of life, what are the major drivers of acquisition, and
what are the implications on infant health and well-being.
Future studies should explore the source of acquisition of
resistance in infants, to understand whether such resistance
is primarily acquired from the environment, vertically from
the child’s mother, or through selective pressure from
pediatric antibiotic use.
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